Kriya Therapeutics

Clinical-stage biopharma developing gene therapies for common chronic diseases such as geographic atrophy, thyroid eye disease and type 1 diabetes.

View on the globe

$320MEquity raised in 2025–20262025 $320M · 2026 — · 1 equity round
$320MEquity raised, all time1 equity round sourced so far
—Latest valuationnot disclosed

Rounds over time log-scaled amounts

Funding history: 1 round from 10 Sep 2025 to 10 Sep 2025, $320M equity disclosed. Earlier rounds exist but are not sourced.10 Sep 2025: Series D, $320M$10M$30M$100M$300M$1BEarlier rounds exist but are not sourced yet← earlier rounds not sourcedest. 2019Q2Q3Q42026Q2Equity round10 Sep 2025 · Series D · $320M · led by Patient Square Capital, Premji InvestSeries D · $320M
Funding history: 1 round from 10 Sep 2025 to 10 Sep 2025, $320M equity disclosed. Earlier rounds exist but are not sourced.10 Sep 2025: Series D, $320M$10M$30M$100M$300M$1BEarlier rounds exist but are not sourced yetearlier rounds not sourced’19Q2Q3Q42026Q2Equity round10 Sep 2025 · Series D · $320M · led by Patient Square Capital, Premji Invest$320M

Funding history 1 round · 1 source

Earlier rounds not yet sourced. Kriya Therapeutics was founded in 2019 and raised before 10 Sep 2025; only the rounds below are sourced so far, so its all-time equity total understates its history.

  1. Series D
    Amount$320M
    Post-money—
    ✓ Confirmed
    Lead
    Patient Square Capital, Premji Invest
    Also
    Peter Thiel, Narya Capital, The T1D Fund
    Note
    Oversubscribed, priced at a significant step-up from the prior round. A separate August 2025 'Series C of $313M' seen in a list could not be sourced and is not recorded. The company's 2021 Series B was led by Patient Square (amount not stated in the release).
    Sources
  2. Earlier rounds not yet sourced

Investors 5

  • Patient Square Capital1
  • Premji Invest1
  • Narya Capital
  • Peter Thiel
  • The T1D Fund

Highlighted investors led at least one equity round; the number is equity rounds taken part in.

Related companies shared investors

Figures in USD at the time of each round. See the methodology for how rounds are sourced and verified. Kriya Therapeutics and its logo are trademarks of their owners, used here for identification only.